PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

yes, i am thinking the same with regard to phase3 valuation. it...

  1. 77 Posts.
    lightbulb Created with Sketch. 30
    yes, i am thinking the same with regard to phase3 valuation. it speaks volumes to the share holder list.
    who of any significance is on that list. is there a dedicated healthcare fund on that list, no.
    don't they have consultants doing public relations work for them in the usa?
    somewhere on hotcopper someone spoke about the cash burn situation, it was $70m cash balance in march, burning at $10m quarter, with expectations of doubling when trials are allowed to begin. the math would say they are out of cash by june 2024, so ljsm, there must be a cap raise hangover.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.